Iberia Pharma Launches KeyCi Science-Backed Skincare Brand

Iberia Pharma Launches KeyCi Science-Backed Skincare Brand

India Pharma Outlook Team | Friday, 17 October 2025

 Iberia Pharmaceuticals, KeyCi

Iberia Pharmaceuticals, a leading name in skincare, has launched KeyCi, a science-backed skincare brand designed for modern consumers aged 18–45. KeyCi offers high-performance, dermatologically tested products that are vegan, cruelty-free, alcohol-free, paraben-free and FDA approved.

Developed by dermatologists and supported by pharma-grade R&D, KeyCi’s range of four products aim to bridge the gap between daily skincare and clinical-grade performance with formulations that address Indian skin specifically.

KeyCi offerings will be on e-commerce platforms. Gender-neutral and suitable for all skin types, these products are founded on the core principles of Confidence, Care, and Science. Beyond formulations, KeyCi reflects Iberia’s values of sustainability and conscious production.

Also Read: Advanced Formulation Technologies Streamlining Global Pharma Innovation

Packaging has been designed with recyclable materials and minimal plastic to reduce waste, ensuring premium skincare aligns with eco-friendly living. From responsible sourcing and green materials to research-based innovation, each KeyCi product is a testament to the brand's commitment to mindful beauty.

"KeyCi has been in development for several years, with Iberia’s in-house research team working closely with dermatologists and clinical partners to create products that are safe, effective and suited to local conditions. Unlike global products adapted for India, KeyCi has been meticulously developed from the ground up, with formulations precisely designed to address the unique climate, and lifestyle requirements of Indian consumers, said Nitin Jain, Founder, Iberia Pharmaceuticals.

Crafted with potent actives like Ceramides, Hyaluronic Acid, Vitamin C, and Peptides, KeyCi formulations use advanced delivery systems for visible, lasting results. KeyCi’s four products focus on long-term skin health: the Barrier Repair Ultra Hydrating Cleanser with tri-ceramides, fermented rice water, and 4KDA hyaluronic acid; the Skin Brightening face Serum with 4D hyaluronic acid, Kakadu plum, niacinamide, and Vitamin C; the 24-Hour Hydrating Cream with copper tripeptide-1 and encapsulated vitamins; and the InvisiBlock Sunscreen SPF 50 PA++++ with encapsulated UV filters, niacinamide, CICA, aloe vera, and Vitamin E for broad-spectrum protection without a white cast.

“Our new product line represents the next step in our journey as we aim to expand our presence significantly. With this launch, KeyCi delivers affordable luxury, premium-quality skincare that is safe, ethical and accessible. All formulations are dermatologically tested and free from alcohol, parabens, sulfates and artificial fragrances", said Saurav Ojha, Co-Founder Iberia Pharmaceuticals.

Iberia Pharmaceuticals has established itself as a trusted name in pharma-grade skincare through brands such as Sesderma, Dermpix, Noreva, Metacare and Mediderma. With KeyCi, Iberia extends this legacy to a new generation of conscious consumers seeking products that are both effective and ethical.

Also Read: Personalized Hygiene Care Tailoring Products to Individual Needs

The brand also mirrors Iberia’s broader expansion strategy. With an investment of Rs 70 crore, Iberia is setting up a new manufacturing facility in Haryana that will produce over 12 million units annually and create more than 600 jobs.

Iberia has been in service of the dermatology needs of India and the world for more than a few decades. What started as a single vision, it has blossomed into a full-scale operation with advanced manufacturing facilities and science, including R&D facilities, and nationwide distribution. Iberia is steadily becoming a name synonymous with reliability in dermatology and wellness.

© 2025 India Pharma Outlook. All Rights Reserved.